David M. Stevens

513 total citations
20 papers, 402 citations indexed

About

David M. Stevens is a scholar working on Biomaterials, Molecular Biology and General Health Professions. According to data from OpenAlex, David M. Stevens has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 5 papers in Molecular Biology and 4 papers in General Health Professions. Recurrent topics in David M. Stevens's work include Nanoparticle-Based Drug Delivery (5 papers), biodegradable polymer synthesis and properties (3 papers) and Advanced Drug Delivery Systems (3 papers). David M. Stevens is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), biodegradable polymer synthesis and properties (3 papers) and Advanced Drug Delivery Systems (3 papers). David M. Stevens collaborates with scholars based in United States and United Kingdom. David M. Stevens's co-authors include Eva Harth, Stęphan T. Stern, Christopher Cox, Arthur B. Elster, Viking A. Hedberg, Jonathan D. Klein, Marjorie Allan, Dain B. Beezer, Sarah Tempelaar and Andrew P. Dove and has published in prestigious journals such as PEDIATRICS, Cancer Research and Journal of Controlled Release.

In The Last Decade

David M. Stevens

18 papers receiving 393 citations

Peers

David M. Stevens
Jacqueline J. Blank United States
Jane B. Taylor United States
Sue Campbell United Kingdom
Ruoyu Yin China
David M. Stevens
Citations per year, relative to David M. Stevens David M. Stevens (= 1×) peers Ashish Dhawan

Countries citing papers authored by David M. Stevens

Since Specialization
Citations

This map shows the geographic impact of David M. Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Stevens more than expected).

Fields of papers citing papers by David M. Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Stevens. The network helps show where David M. Stevens may publish in the future.

Co-authorship network of co-authors of David M. Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Stevens. A scholar is included among the top collaborators of David M. Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Stevens. David M. Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burks, Julian, Shweta Tiwary, David M. Stevens, et al.. (2025). PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. Journal for ImmunoTherapy of Cancer. 13(3). e009539–e009539.
2.
Stevens, David M., et al.. (2022). Beyond Primary Care: Renewing the Community Health Center Vision for Today's Health Crisis. Journal of Health Care for the Poor and Underserved. 33(2). 1123–1128.
3.
Stevens, David M., Pavan P. Adiseshaiah, Edward Cedrone, et al.. (2020). Application of a Scavenger Receptor A1-Targeted Polymeric Prodrug Platform for Lymphatic Drug Delivery in HIV. Molecular Pharmaceutics. 17(10). 3794–3812. 14 indexed citations
4.
Stevens, David M., Rachael M. Crist, & Stęphan T. Stern. (2020). Nanomedicine Reformulation of Chloroquine and Hydroxychloroquine. Molecules. 26(1). 175–175. 21 indexed citations
5.
Hu, Yingwen, et al.. (2019). Total drug quantification in prodrugs using an automated elemental analyzer. Drug Delivery and Translational Research. 9(6). 1057–1066. 3 indexed citations
6.
Gerstein, Maya T., Anne Rossier Markus, Kan Z. Gianattasio, et al.. (2019). Choosing between medical management and liver transplant in urea cycle disorders: A conceptual framework for parental treatment decision‐making in rare disease. Journal of Inherited Metabolic Disease. 43(3). 438–458. 9 indexed citations
7.
Stern, Stęphan T., Marilyn N. Martinez, & David M. Stevens. (2016). When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?. Drug Metabolism and Disposition. 44(12). 1934–1939. 33 indexed citations
8.
Beezer, Dain B., et al.. (2016). One-pot polyglycidol nanogels via liposome master templates for dual drug delivery. Journal of Controlled Release. 244(Pt B). 366–374. 26 indexed citations
9.
Stevens, David M., et al.. (2015). Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. Journal of Controlled Release. 220(Pt B). 751–757. 49 indexed citations
10.
Ndong, Jean De La Croix, David M. Stevens, Guillaume Vignaux, et al.. (2015). Combined MEK Inhibition and BMP2 Treatment Promotes Osteoblast Differentiation and Bone Healing in Nf1Osx–/– Mice. Journal of Bone and Mineral Research. 30(6). 1118–1118. 3 indexed citations
11.
Ndong, Jean De La Croix, David M. Stevens, Guillaume Vignaux, et al.. (2014). Combined MEK Inhibition and BMP2 Treatment Promotes Osteoblast Differentiation and Bone Healing in Nf1Osx−/− Mice. Journal of Bone and Mineral Research. 30(1). 55–63. 33 indexed citations
12.
Stevens, David M., et al.. (2014). Semibranched polyglycidols as “fillers” in polycarbonate hydrogels to tune hydrophobic drug release. Polymer Chemistry. 6(7). 1096–1102. 17 indexed citations
13.
Stevens, David M., et al.. (2014). An assessment of nanosponges for intravenous and oral drug delivery of BCS class IV drugs: Drug delivery kinetics and solubilization. Polymer Chemistry. 5(11). 3551–3551. 14 indexed citations
14.
Stevens, David M., et al.. (2013). Practical polymerization of functionalized lactones and carbonates with Sn(OTf)2 in metal catalysed ring-opening polymerization methods. Polymer Chemistry. 4(8). 2470–2470. 14 indexed citations
15.
Stevens, David M., Sarah Tempelaar, Andrew P. Dove, & Eva Harth. (2012). Nanosponge Formation from Organocatalytically Synthesized Poly(carbonate) Copolymers. ACS Macro Letters. 1(7). 915–918. 54 indexed citations
16.
Porterfield, Deborah S, et al.. (2010). The Diabetes Primary Prevention Initiative Interventions Focus Area. American Journal of Preventive Medicine. 39(3). 235–242. 3 indexed citations
17.
Kim, James, Ruoyu Gong, J. Jack Lee, et al.. (2009). Abstract #5582: Itraconazole as a novel Hedgehog pathway antagonist in cancer therapy. Cancer Research. 69. 5582–5582. 1 indexed citations
18.
Hayashi, A. Seiji, et al.. (2009). Health Center Data Warehouses: Opportunities and Challenges for Quality Improvement. 1 indexed citations
19.
Klein, Jonathan D., Marjorie Allan, Arthur B. Elster, et al.. (2001). Improving Adolescent Preventive Care in Community Health Centers. PEDIATRICS. 107(2). 318–327. 104 indexed citations
20.
Stevens, David M., et al.. (1999). Applying HEDIS® Clinical Measures to Community Health Centers: A Feasibility Study. Journal of Ambulatory Care Management. 22(4). 53–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026